These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16162017)

  • 1. Understanding the COX-2/NSAID dilemma.
    Roth SH
    Drugs; 2005; 65(14):1915-7. PubMed ID: 16162017
    [No Abstract]   [Full Text] [Related]  

  • 2. The murky world of the COX-2-selective agents.
    Bjarnason I; Thjodleifsson B
    Inflammopharmacology; 2005; 13(4):381-93. PubMed ID: 16354391
    [No Abstract]   [Full Text] [Related]  

  • 3. [Non-selective NSAIDs and coxibs: what are myths, what are facts?].
    MMW Fortschr Med; 2013 Jun; 155(12):56-7. PubMed ID: 23923320
    [No Abstract]   [Full Text] [Related]  

  • 4. COX-2 inhibitors and Celebrex: safe or suspect?
    Health News; 1999 Jun; 5(7):4. PubMed ID: 10932776
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors.
    Scheiman JM; Yeomans ND; Talley NJ; Vakil N; Chan FK; Tulassay Z; Rainoldi JL; Szczepanski L; Ung KA; Kleczkowski D; Ahlbom H; Naesdal J; Hawkey C
    Am J Gastroenterol; 2006 Apr; 101(4):701-10. PubMed ID: 16494585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Further definition of the role of COX-2 inhibitors and NSAIDs in patients with nociceptive pain].
    Nurmohamed MT
    Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1313; author reply 1313-4. PubMed ID: 17624165
    [No Abstract]   [Full Text] [Related]  

  • 7. [Every 1000th long-term user dies of gastric complications. What gastric protection for which NSAID patients?].
    Stiefelhagen P
    MMW Fortschr Med; 2006 Feb; 148(5):11. PubMed ID: 16518929
    [No Abstract]   [Full Text] [Related]  

  • 8. A COX-2-specific inhibitor plus a proton-pump inhibitor: is this a reasonable approach to reduction in NSAIDs' GI toxicity?
    Cryer B
    Am J Gastroenterol; 2006 Apr; 101(4):711-3. PubMed ID: 16635218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug safety of NSAIDs and COX-2 inhibitors].
    Herdegen T; Fauler J
    Med Monatsschr Pharm; 2006 Apr; 29(4):122-8. PubMed ID: 16628961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs.
    Scheiman JM
    Gastroenterol Clin North Am; 2009 Jun; 38(2):305-14. PubMed ID: 19446260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of pain in rheumatic diseases].
    Luttosch F; Baerwald C
    Dtsch Med Wochenschr; 2011 Aug; 136(31-32):1598-600. PubMed ID: 21809251
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gastric protective pain therapy. What is the advantage of new COX-2 inhibitors?].
    Hinz B; Brune K
    MMW Fortschr Med; 2000 Mar; 142(11):39-40. PubMed ID: 10786088
    [No Abstract]   [Full Text] [Related]  

  • 13. [Insight on the clinical pharmacology of non-steroidal anti-inflammatory drugs].
    Maddison JE
    Tijdschr Diergeneeskd; 2010 Jan; 135(2):54-8. PubMed ID: 20344966
    [No Abstract]   [Full Text] [Related]  

  • 14. [NSAID therapy. Gastrointestinal risks of classic NSAID are underestimated].
    MMW Fortschr Med; 2010 May; 152(20):46-7. PubMed ID: 20552882
    [No Abstract]   [Full Text] [Related]  

  • 15. Pain medications. What you should know.
    Mayo Clin Health Lett; 2007 Sep; 25(9):4-5. PubMed ID: 18240408
    [No Abstract]   [Full Text] [Related]  

  • 16. [Coronary risks with NSAID and coxibs. The end of hysteria].
    Einecke D
    MMW Fortschr Med; 2006 Nov; 148(48):10, 12. PubMed ID: 17615760
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in ulcerogenic response to non-steroidal antiinflammatory drugs (NSAIDs) in the gastrointestine during chronic arthritis].
    Kato S; Takeuchi K
    Nihon Yakurigaku Zasshi; 2006 Aug; 128(2):88-92. PubMed ID: 16943643
    [No Abstract]   [Full Text] [Related]  

  • 18. From prostaglandin replacement to specific COX-2 inhibition: a critical appraisal.
    Kremer J
    J Rheumatol Suppl; 2000 Oct; 60():9-12. PubMed ID: 11032096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of cox-2 selective nonsteroidal antiinflammatory drugs for postsurgical pain.
    Babul N; Sloan P; Lipman AG
    Anesth Analg; 2006 Feb; 102(2):645-6; author reply 646. PubMed ID: 16428581
    [No Abstract]   [Full Text] [Related]  

  • 20. To use or not to use: the dilemma of NSAIDs and craniotomy.
    Umamaheswara Rao GS; Gelb AW
    Eur J Anaesthesiol; 2009 Aug; 26(8):625-6. PubMed ID: 19584610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.